Postoperative Adjuvant Dupilumab Improved Immediate Recovery in Patients With Advanced Type 2 Chronic Rhinosinusitis: An Exploratory Pilot Study

Int Forum Allergy Rhinol. 2025 Jan 6. doi: 10.1002/alr.23523. Online ahead of print.

Authors

Yan-Ting Ho¹, Hsiang-Sheng Wang², Ta-Jen Lee¹, Po-Hung Chang^{1

3}, Chia-Chen Wu¹, Chia-Hsiang Fu^{1

3}

Affiliations

¹ Department of Otolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
² Department of Pathology, Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
³ Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

PMID: 39761368
DOI: 10.1002/alr.23523

No abstract available

Keywords: adjuvant biologic | chronic rhinosinusitis | endoscopic sinus surgery | nasal polyps | olfaction | type 2 inflammation | Sinonasal Outcome Test‐22 (SNOT‐22).

Grants and funding

NSTC 113-2314-B-182A-043/Ministry of Science and Technology